Making better chimeric antigen receptors for adoptive T-cell therapy

MV Maus, CH June - Clinical cancer research, 2016 - AACR
Chimeric antigen receptors (CAR) are engineered fusion proteins constructed from antigen
recognition, signaling, and costimulatory domains that can be expressed in cytotoxic T cells …

Phylodynamics for cell biologists

T Stadler, OG Pybus, MPH Stumpf - Science, 2021 - science.org
BACKGROUND The birth, death, and diversification of individuals are events that drive
biological processes across all scales. This is true whether the individuals in question …

Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1

T Umezu, H Tadokoro, K Azuma… - Blood, The Journal …, 2014 - ashpublications.org
Exosomes are small endosome-derived vesicles containing a wide range of functional
proteins, mRNA, and miRNA. Exosomal miRNA from cancer cells helps modulate the …

[HTML][HTML] Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

AL Garfall, EA Stadtmauer, WT Hwang, SF Lacey… - JCI insight, 2018 - ncbi.nlm.nih.gov
BACKGROUND. Multiple myeloma is usually fatal due to serial relapses that become
progressively refractory to therapy. CD19 is typically absent on the dominant multiple …

[HTML][HTML] European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

M Engelhardt, E Terpos, M Kleber, F Gay, R Wäsch… - …, 2014 - ncbi.nlm.nih.gov
Multiple myeloma management has undergone profound changes in the past thanks to
advances in our understanding of the disease biology and improvements in treatment and …

Relapse-fated latent diagnosis subclones in acute B lineage leukemia are drug tolerant and possess distinct metabolic programs

SM Dobson, L García-Prat, RJ Vanner, J Wintersinger… - Cancer discovery, 2020 - AACR
Disease recurrence causes significant mortality in B-progenitor acute lymphoblastic
leukemia (B-ALL). Genomic analysis of matched diagnosis and relapse samples shows …

Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

B Paiva, T Paino, JM Sayagues… - Blood, The Journal …, 2013 - ashpublications.org
Circulating myeloma tumor cells (CTCs) as defined by the presence of peripheral blood (PB)
clonal plasma cells (PCs) are a powerful prognostic marker in multiple myeloma (MM) …

Chimeric antigen receptor-modified T cell therapy in multiple myeloma: beyond B cell maturation antigen

M Timmers, G Roex, Y Wang… - Frontiers in …, 2019 - frontiersin.org
Chimeric antigen receptor (CAR)-modified T cell therapy is a rapidly emerging
immunotherapeutic approach that is revolutionizing cancer treatment. The impressive …

Differentiation stage of myeloma plasma cells: biological and clinical significance

B Paiva, N Puig, MT Cedena, BG de Jong, Y Ruiz… - Leukemia, 2017 - nature.com
The notion that plasma cells (PCs) are terminally differentiated has prevented intensive
research in multiple myeloma (MM) about their phenotypic plasticity and differentiation …

IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors

M Jourdan, M Cren, N Robert, K Bolloré, T Fest… - Leukemia, 2014 - nature.com
The recent understanding of plasma cell (PC) biology has been obtained mainly from
murine models. The current concept is that plasmablasts home to the BM and further …